Archean Chemical Industries Ltd
Archean Chemical Industries Limited is India's largest exporter of bromine and industrial salt in Fiscal 2021. The company is the leading specialty marine chemical manufacturer in India and is focused on producing and exporting bromine, industrial salt, and sulphate of potash to customers around the world.[1]
- Market Cap ₹ 5,295 Cr.
- Current Price ₹ 429
- High / Low ₹ 660 / 427
- Stock P/E 35.8
- Book Value ₹ 166
- Dividend Yield 0.58 %
- ROCE 10.6 %
- ROE 7.96 %
- Face Value ₹ 2.00
Pros
- Company has been maintaining a healthy dividend payout of 17.2%
- Company's working capital requirements have reduced from 59.5 days to 31.8 days
Cons
- The company has delivered a poor sales growth of 7.05% over past five years.
- Company has a low return on equity of 12.7% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| 439 | 566 | 608 | 741 | 1,130 | 1,441 | 1,330 | 1,014 | 1,042 | 1,149 | |
| Sales growth | +29% | +8% | +22% | +53% | +27% | -8% | -24% | +3% | +8% | |
| 356 | 497 | 460 | 478 | 663 | 807 | 865 | 691 | 781 | 894 | |
| Operating Profit | 83 | 69 | 148 | 262 | 467 | 634 | 464 | 323 | 261 | 255 |
| OPM % | 19% | 12% | 24% | 35% | 41% | 44% | 35% | 32% | 25% | 22% |
| 6 | 121 | 8 | 14 | 13 | 44 | 47 | 9 | 47 | 54 | |
| Interest | 102 | 114 | 122 | 130 | 162 | 97 | 10 | 9 | 18 | 27 |
| Depreciation | 73 | 47 | 52 | 55 | 67 | 69 | 70 | 73 | 80 | 80 |
| Profit before tax | -85 | 29 | -17 | 90 | 251 | 513 | 431 | 250 | 210 | 202 |
| Tax % | -7% | -41% | 105% | 26% | 25% | 25% | 25% | 26% | 27% | |
| -79 | 41 | -36 | 67 | 189 | 384 | 322 | 185 | 154 | 148 | |
| EPS in Rs | -15.83 | 4.26 | -3.70 | 6.91 | 19.58 | 31.18 | 26.12 | 14.98 | 12.50 | 11.97 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 8% | 11% | 20% | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | -10% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | -26% |
| TTM: | -28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -6% |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 13% |
| Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 19 | 19 | 19 | 19 | 25 | 25 | 25 | 25 | 25 |
| Reserves | -38 | 24 | -12 | 55 | 243 | 1,408 | 1,682 | 1,855 | 1,973 | 2,025 |
| 968 | 754 | 854 | 904 | 897 | 69 | 39 | 108 | 322 | 403 | |
| 316 | 439 | 568 | 457 | 372 | 254 | 246 | 261 | 252 | 300 | |
| Total Liabilities | 1,256 | 1,237 | 1,430 | 1,434 | 1,532 | 1,756 | 1,991 | 2,249 | 2,571 | 2,751 |
| 940 | 914 | 882 | 1,042 | 1,086 | 1,097 | 1,086 | 1,071 | 1,067 | 1,069 | |
| CWIP | 0 | 9 | 193 | 19 | 17 | 33 | 21 | 28 | 53 | 73 |
| Investments | 0 | 0 | 47 | 41 | 16 | 215 | 347 | 350 | 268 | 432 |
| 316 | 314 | 308 | 332 | 412 | 410 | 537 | 800 | 1,184 | 1,177 | |
| Total Assets | 1,256 | 1,237 | 1,430 | 1,434 | 1,532 | 1,756 | 1,991 | 2,249 | 2,571 | 2,751 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 39 | 312 | 148 | 119 | 327 | 498 | 389 | 169 | 189 | |
| 0 | -25 | -197 | -2 | -128 | -288 | -260 | -196 | -339 | |
| -87 | -252 | 26 | -110 | -224 | -212 | -91 | 19 | 138 | |
| Net Cash Flow | -48 | 35 | -23 | 7 | -24 | -2 | 39 | -8 | -13 |
| Free Cash Flow | 33 | 281 | -4 | 109 | 231 | 402 | 345 | 75 | 128 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 47% | 456% | 100% | 45% | 70% | 82% | 107% | 70% | 95% |
Ratios
Standalone / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 43 | 27 | 34 | 49 | 30 | 43 | 62 | 48 |
| Inventory Days | 830 | 238 | 532 | ||||||
| Days Payable | 1,035 | 398 | 415 | ||||||
| Cash Conversion Cycle | -183 | -116 | 27 | 34 | 49 | 30 | 160 | 62 | 48 |
| Working Capital Days | -70 | 0 | -38 | 22 | 50 | 41 | 54 | 92 | 32 |
| ROCE % | 3% | 13% | 24% | 39% | 46% | 26% | 16% | 11% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Bromine Sales Volume MT |
|
|||||
| Industrial Salt Sales Volume MT |
||||||
| Industrial Salt Installed Capacity MTPA |
||||||
| Total Customer Count Count |
||||||
| Bromine Installed Capacity MTPA |
||||||
| Acume (Bromine Derivatives) Capacity Utilization % |
||||||
| Bromine Derivatives (Acume) Sales Volume MT |
||||||
| SOP (Sulphate of Potash) Sales Volume MT |
||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Earnings call recording for quarter and half year ended September 30, 2026 posted online.
- Announcement under Regulation 30 (LODR)-Investor Presentation
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper publication of un-audited financial results of the Company for the quarter and half year ended September 30, 2026
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
- Allotment of shares under Company Employee Stock Option Plan 2022
- Unaudited Financial Results For The Quarter & Half Year Ended September 30, 2026
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from web
Concalls
-
Nov 2026PPT REC
-
Aug 2026Transcript PPT
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript REC
-
Aug 2024PPT REC
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript
-
May 2023Transcript PPT REC
-
Feb 2023Transcript
-
Feb 2023Transcript PPT REC
Business Area[1]
The company is specialty marine chemicals company engaged in the production of Industrial Salt, Bromine and Sulphate of Potash (SOP) from natural sea brine resources. The company operates an integrated business model supported by strategic brine reserves and captive port infrastructure, while also expanding into bromine derivatives, specialty chemicals, energy storage and semiconductor materials to strengthen its long-term growth portfolio.